Total Visits

Views
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study96

Total Visits Per Month

September 2023October 2023November 2023December 2023January 2024February 2024March 2024April 2024May 2024June 2024July 2024
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study100563244720

File Visits

Views
FBargiela_Discontinuation.pdf120

Top country views

Views
United States53
China7
Sweden7
Ireland6
Australia4
Spain3
Argentina2
Belgium2
United Kingdom2
Canada1

Top cities views

Views
Ashburn10
Menlo Park10
Fairfield8
Mountain View7
Dublin6
Cambridge5
Hangzhou5
San Diego3
A Coruña2
Boardman2